Enanta Pharmaceuticals Inc
Research Enanta Pharmaceuticals Inc (ENTA) on Bullrun: market cap USD 364.00M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerENTA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 364.00M
- Financial periodQ2 2026
- RevenueUSD 14.36M
- Net income-USD 19.50M
- Free cash flow-USD 9.98M
Valuation Snapshot
latest market cap is USD 364.00M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 65.32M | -USD 81.89M | -USD 32.17M | n/a | -3.84 | USD 32.30M | USD 57.90M | USD 64.72M |
| FY2024 | USD 67.64M | -USD 116.05M | -USD 96.71M | n/a | -5.48 | USD 37.23M | USD 55.47M | USD 128.81M |
| FY2023 | USD 79.20M | -USD 133.82M | -USD 112.21M | n/a | -6.38 | USD 85.39M | USD 26.51M | USD 216.74M |
| FY2022 | USD 86.16M | -USD 121.76M | -USD 86.91M | n/a | -5.91 | USD 43.99M | USD 25.26M | USD 321.33M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 364.00M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 457.63M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 122.66M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 198.16M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 967.50M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.53B | n/a | n/a | n/a |
About Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Enanta Pharmaceuticals Inc's market cap?
Enanta Pharmaceuticals Inc's market capitalization is USD 364.00M.
What does Enanta Pharmaceuticals Inc do?
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications.